Analysis of the efficacy of lenalidomide in patients with intermediate-1 risk myelodysplastic syndrome without 5q deletion

The aim of this study was to evaluate the efficacy and adverse effects of lenalidomide in the treatment of intermediate-1 risk non-5q deletion [non-del (5q)] myelodysplastic syndrome (MDS). A total of 30 patients with MDS were classified through G-banding chromosome karyotype analysis and fluorescen...

Descripción completa

Detalles Bibliográficos
Autores principales: YANG, YAN, GAO, SUJUN, FAN, HONGQIONG, LIN, HAI, LI, WEI, WANG, JUAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786804/
https://www.ncbi.nlm.nih.gov/pubmed/24137269
http://dx.doi.org/10.3892/etm.2013.1218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786804/
https://www.ncbi.nlm.nih.gov/pubmed/24137269
http://dx.doi.org/10.3892/etm.2013.1218

Ejemplares similares